Microbot Medical Inc. — Director's Dealing 2024

Feb 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2024-02-22

Reporting Person: Vaknin Rachel (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-22	Stock Option (Right to Buy)	$1.2684	A	17500	Acquired	2034-02-22	Common Stock, par value $0.01 per share (17500)	Direct
2024-02-22	Stock Option (Right to Buy)	$1.2684	A	17500	Acquired	2034-02-22	Common Stock, par value $0.01 per share (17500)	Direct

Footnotes

F1: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.